IDiyas

For the Inventor, By the Inventor

Ness Ziona, Israel

Amorphical Ltd.


USPTO Granted Patents = 18



Trademarks = 6

Forward Citations = 17

Loading Chart...
Loading Chart...

22 inventors (with patents filed for the assignee):

goldMedal Yosef Ben (11 out of 12 patents)

silverMedal Yigal Dov Blum (8 out of 38 patents)

bronzeMedal Assaf Shechter (4 out of 7 patents)

4.  Amir Sagi (4 out of 11 patents)

5.  Oren Meiron (4 out of 4 patents)

6.  Abraham Shahar (3 out of 3 patents)

7.  Amir Arav (3 out of 11 patents)

8.  Hagay Moshe (2 out of 2 patents)

9.  Ben Ashkenazi (2 out of 2 patents)

10.  Galit Shaltiel-Gold (2 out of 2 patents)

11.  Michal Daniely (2 out of 2 patents)

12.  Shmuel Bentov (2 out of 2 patents)

13.  Amir Berman (2 out of 3 patents)

14.  Binyamin Ashkenazi (2 out of 2 patents)

15.  Sharon Hershkovitz (2 out of 2 patents)


18 patents:

1. 12357656 - Amorphous calcium carbonate for improving athletic performance (2025-07-15),
2. 12121538 - Compositions of amorphous calcium carbonate for inhalation, sublingual or buccal administration (2024-10-22),
3. 12115184 - Amorphous calcium carbonate stabilized with polyphosphates or bisphosphonates (2024-10-15),
4. 12060573 - Stabilized amorphous calcium carbonate as a supplement for cell culture media (2024-08-13),
5. 11602542 - Non-aqueous liquid and semi-solid formulations of amorphous calcium carbonate (2023-03-14),
6. 11446327 - Encapsulated amorphous calcium carbonate compositions (2022-09-20),
7. 11207347 - Stabilized amorphous calcium carbonate for treatment of neurological, muscular and infertility diseases or conditions (2021-12-28),
8. 11052108 - Amorphous calcium carbonate for treating a leukemia (2021-07-06),
9. 11052107 - Amorphous calcium carbonate stabilized with polyphosphates or bisphosphonates (2021-07-06),
10. 11033576 - Compositions of amorphous calcium carbonate for inhalation, sublingual or buccal administration (2021-06-15),
11. 10758566 - Stabilized amorphous calcium carbonate for treatment of neurological, muscular and infertility diseases or conditions (2020-09-01),
12. 10758565 - Compositions of amorphous calcium carbonate for inhalation, sublingual or buccal administration (2020-09-01),
13. 10688124 - Amorphous calcium carbonate for the treatment of calcium malabsorption and metabolic bone disorders (2020-06-23),
14. 10328100 - Stable amorphous calcium carbonate comprising synthetic phosphorylated peptides (2019-06-25),
15. 10125262 - Method for producing stabilized amorphous calcium carbonate (2018-11-13),
Amorphical Ltd. is a biopharmaceutical company focused on the research, development, and commercialization of innovative treatments for osteoporosis and related bone disorders. With a commitment to improving the lives of patients, Amorphical leverages its proprietary technology to develop novel calcium-based drugs that have the potential to revolutionize bone health. Through strategic partnerships and collaborations, Amorphical aims to make a lasting impact in the field of osteoporosis therapy.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

18 Patents

#4 in Ness Ziona

#319 in Israel

#33,147 in the World

...
Ness Ziona, Israel

Amorphical Ltd.

Forward Citations = 17

22 inventors:

goldMedal Yosef Ben (11 out of 12 patents)

silverMedal Yigal Dov Blum (8 out of 38 patents)

bronzeMedal Assaf Shechter (4 out of 7 patents)

4.  Amir Sagi (4 out of 11 patents)

5.  Oren Meiron (4 out of 4 patents)

Please report any incorrect information to support@idiyas.com
Loading…